We’re delighted to announce the start of an international research project under the European Consortium for Continuous Pharmaceutical Manufacturing (ECCPM). The collaborative efforts from industrial and scientific partners aim to develop continuous manufacturing practices and improve the quality and cost-effectiveness of nanoparticles-based drug products. Utilizing cutting-edge technology and innovative techniques, we’re paving the way for a new era of production and nanomedicine.

This week, SpeakPharma interviews David Lescuyer, CEO, and Benoit Mougeot, CFO, of Skyepharma, a fully integrated Frenche CDMO for complex oral solid dosage forms. Over the last six years, Skyepharma has transformed itself from a basic contact manufacturing organization (CMO) to an agile, expert, and differeniated contract development and manufacturing organization (CDMO). See more in … Continue reading Skyepharma: the specialized CDMO growing in double digits

Pour se démarquer des autres sous-traitants pharmaceutiques, Skyepharma fait le choix de l’innovation. Un choix audacieux que nous expliquent David Lescuyer, président et directeur général, et Laurent Rigaudeau, directeur commercial.

View Fullscreen

View Fullscreen

View Fullscreen

Skyepharma recently decided to partner with Veratrak to answer customers and market’s needs in terms of exchange of data. Indeed, the amount and the size of documents exchanged between CDMO and their partners is sharply and constantly increasing. As data integrity and confidentiality are now additional constraints to take into account, it became critical for … Continue reading Why using the Veratrak plateform ?

It is an exciting time for our company, with the June 9th, 2021, announcement of a management buyout (MBO) and the establishment of Skyepharma as an independent company. What is the rationale behind this deal ? {{ vc_btn: title=Read+full+article+here&style=gradient&gradient_color_2=vista-blue&align=center&css_animation=appear&link=url%3Ahttps%253A%252F%252Fpharmaboardroom.com%252Fsponsored%252Fnewly-independent-cdmo-skyepharma-looks-to-expansion }} You liked this reading? Feel free to contact us ! Your name Your email Your … Continue reading Newly Independent CDMO Skyepharma Looks to Expansion

What is the PMI? The PMI, Project Management Institute, is a non-profit professional association, which mainly addresses project managers. It is this organization that governs the "bible" of the project manager: PMBOK or Project Management Body of Knowledge, but also delivers the PMP or Project Management Professional certification. Internationally recognized, this qualification allows Skyepharma to … Continue reading PMI : Project Management Institute

In pharmaceutical industries, UHPLC is becoming more and more essential due to its accessibility and its chromatographic performance. Skyepharma’s AD/QC laboratory has strengthened its analytical range by the acquisition of H-Class acquity UPLCs, state of art equipment in liquid chromatography field for routine analysis and analytical development. Chromatographic analysis, the laboratory core analysis The UHPLC … Continue reading UHPLC : The analytical answer to current needs